Control of Cell Proliferation,Organ Growth,and DNA Damage Response Operate Independently of Dephosphorylation of the Arabidopsis Cdk1 Homolog CDKA;1

Entry into mitosis is universally controlled by cyclin-dependent kinases (CDKs). A key regulatory event in metazoans and fission yeast is CDK activation by the removal of inhibitory phosphate groups in the ATP binding pocket catalyzed by Cdc25 phosphatases. In contrast with other multicellular organisms, we show here that in the flowering plant Arabidopsis thaliana, cell cycle control does not depend on sudden changes in the phosphorylation pattern of the PSTAIRE-containing Cdk1 homolog CDKA;1. Consistently, we found that neither mutants in a previously identified CDC25 candidate gene nor plants in which it is overexpressed display cell cycle defects. Inhibitory phosphorylation of CDKs is also the key event in metazoans to arrest cell cycle progression upon DNA damage. However, we show here that the DNA damage checkpoint in Arabidopsis can also operate independently of the phosphorylation of CDKA;1. These observations reveal a surprising degree of divergence in the circuitry of highly conserved core cell cycle regulators in multicellular organisms. Based on biomathematical simulations, we propose a plant-specific model of how progression through the cell cycle could be wired in Arabidopsis.     

Construction of a Gene Knockout System for Application in Paenibacillus alvei CCM 2051T,Exemplified by the S-Layer Glycan Biosynthesis Initiation Enzyme WsfP

The gram-positive bacterium Paenibacillus alvei CCM 2051^T is covered by an oblique surface layer (S-layer) composed of glycoprotein subunits. The S-layer O-glycan is a polymer of [→3)-β-d-Galp-(1[α-d-Glcp-(1→6)]→4)-β-d-ManpNAc-(1→] repeating units that is linked by an adaptor of -[GroA-2→OPO₂→4-β-d-ManpNAc-(1→4)]→3)-α-l-Rhap-(1→3)-α-l-Rhap-(1→3)-α-l-Rhap-(1→3)-β-d-Galp-(1→ to specific tyrosine residues of the S-layer protein. For elucidation of the mechanism governing S-layer glycan biosynthesis, a gene knockout system using bacterial mobile group II intron-mediated gene disruption was developed. The system is further based on the sgsE S-layer gene promoter of Geobacillus stearothermophilus NRS 2004/3a and on the Geobacillus-Bacillus-Escherichia coli shuttle vector pNW33N. As a target gene, wsfP, encoding a putative UDP-Gal:phosphoryl-polyprenol Gal-1-phosphate transferase, representing the predicted initiation enzyme of S-layer glycan biosynthesis, was disrupted. S-layer protein glycosylation was completely abolished in the insertional P. alvei CCM 2051^T wsfP mutant, according to sodium dodecyl sulfate-polyacrylamide gel electrophoresis evidence and carbohydrate analysis. Glycosylation was fully restored by plasmid-based expression of wsfP in the glycan-deficient P. alvei mutant, confirming that WsfP initiates S-layer protein glycosylation. This is the first report on the successful genetic manipulation of bacterial S-layer protein glycosylation in vivo, including transformation of and heterologous gene expression and gene disruption in the model organism P. alvei CCM 2051^T.Bacterial cell surface layer (S-layer) glycoproteins provide a unique self-assembly matrix that has been optimized by nature for regular and periodic display of glycans with nanometer scale accuracy (21, 31). Exploitation of this self-assembly system for surface display of functional, tailor-made glycans is an attractive alternative to the use of common cell surface anchors (7), with potential areas of application relating to any biological phenomenon that is based on carbohydrate recognition, such as receptor-substrate interaction, signaling, or cell-cell communication. A prerequisite for this endeavor is the availability of an S-layer glycoprotein-covered bacterium that is amenable to genetic manipulation. Despite the high application potential offered by the S-layer glycan display system, there are so far only two reports in the literature dealing with the genetic manipulation of S-layer glycoprotein-carrying bacteria. Both reports concern the gram-negative periodontal pathogen Tannerella forsythia ATCC 43037, but neither of them affects S-layer protein glycosylation (12, 24). In archaea, in contrast, molecular studies of S-layer protein glycosylation are quite advanced (1), but with the archaeal system, S-layer glycoprotein self-assembly, which is a prerequisite for the desired glycan display, has not been manageable in vitro so far.Our model organisms and, hence, candidates for S-layer-mediated glycan display enabled by carbohydrate engineering techniques are members of the Bacillaceae family. Currently, the S-layer glycosylation system of the thermophilic bacterium Geobacillus stearothermophilus NRS 2004/3a is best understood (20, 23, 29, 33, 34). However, a drawback of this organism is its resistance to take up foreign DNA. Although described in the literature (13, 14, 37), transformation of thermophilic bacilli seems to be a strain-specific trait. Based on successful transformation experiments in our laboratory, the mesophilic bacterium Paenibacillus alvei CCM 2051^T (ATCC 6344; DSM 29) (formerly Bacillus alvei [4]) was chosen to set up a system for genetic manipulation. The bacterium is completely covered with an oblique S-layer lattice composed of glycoprotein species. Various aspects of its S-layer, including ultrastructural characterization (27), glycosylation analysis (2, 18), and glycan biosynthesis (11), have been investigated so far. The S-layer O-glycans are polymers of [→3)-β-d-Galp-(1[α-d-Glcp-(1→6)]→4)-β-d-ManpNAc-(1→] repeating units that are linked via the adaptor -[GroA-2→OPO₂→4-β-d-ManpNAc-(1→4)]→3)-α-l-Rhap-(1→3)-α-l-Rhap-(1→3)-α-l-Rhap-(1→3)-β-d- Galp-(1→ to specific tyrosine residues (2, 18) of the S-layer protein SpaA (GenBank accession number {"type":"entrez-nucleotide","attrs":{"text":"FJ751775","term_id":"225546017","term_text":"FJ751775"}}FJ751775).Due to the presence of an identical adaptor saccharide backbone in the S-layer glycan of G. stearothermophilus NRS 2004/3a (29), where its biosynthesis is initiated by the UDP-Gal:phosphoryl-polyprenol Gal-1-phosphate transferase WsaP (33), it was conceivable that a homologous enzyme would initiate S-layer glycosylation in P. alvei CCM 2051^T. Considering that the S-layer protein glycosylation machinery has been found to be encoded by S-layer glycosylation (slg) gene clusters (21), degenerate primers for the rml genes catalyzing the dTDP-l-Rha biosynthesis required for building up the adaptor saccharide of the P. alvei CCM 2051^T S-layer glycan were used to define a point of entry into the glycosylation locus (K. Zarschler, B. Janesch, P. Messner, and C. Schäffer, unpublished data). Chromosome walking revealed the existence of an slg gene cluster of about 24 kb, including an open reading frame (ORF) predicted to encode the initiation enzyme of S-layer protein glycosylation. The corresponding gene, named wsfP, served as a first target for the gene knockout system developed in the course of the present study. This target was chosen because loss of function would be easily screenable, resulting in an S-layer glycosylation-deficient mutant. The gene knockout system constructed for insertional inactivation of the chromosomal wsfP gene of P. alvei CCM 2051^T is based on the commercially available bacterial mobile group II intron Ll.LtrB of Lactococcus lactis, in combination with further components available in our laboratory, including the broad-host-range S-layer gene promoter of sgsE from G. stearothermophilus NRS 2004/3a (22) and the Geobacillus-Bacillus-Escherichia coli shuttle vector pNW33N. Bacterial mobile group II introns are retroelements inserted into specific DNA target sites at high frequency by use of the retrohoming mechanism, by which the excised intron lariat RNA is inserted directly into a DNA target site and is then reverse transcribed by the associated intron-encoded enzyme protein (6, 8, 17). Since the DNA target site is recognized primarily by base pairing of intron RNA, which can be modified, and a few intron-encoded-enzyme-protein recognition positions, these introns can be inserted efficiently into any specific DNA target (9, 15, 35, 40).The aim of this study is the development of a genetic tool for manipulation of S-layer protein glycosylation in P. alvei CCM 2051^T. For proof of concept, we specifically deal with (i) the construction of a broad-host-range gene knockout system based on the L. lactis Ll.LtrB intron; (ii) its modification for specific disruption of the wsfP gene on the P. alvei CCM 2051^T chromosome, encoding the putative initiation enzyme of S-layer glycan biosynthesis; and (iii) the reconstitution of enzyme activity by plasmid-based expression of wsfP and its predicted functional homologue wsaP from G. stearothermophilus NRS 2004/3a.     

The Potential for pathogenicity was present in the ancestor of the Ascomycete subphylum Pezizomycotina

Background  

Previous studies in Ascomycetes have shown that the function of gene families of which the size is considerably larger in extant pathogens than in non-pathogens could be related to pathogenicity traits. However, by only comparing gene inventories in extant species, no insights can be gained into the evolutionary process that gave rise to these larger family sizes in pathogens. Moreover, most studies which consider gene families in extant species only tend to explain observed differences in gene family sizes by gains rather than by losses, hereby largely underestimating the impact of gene loss during genome evolution.     

Toxicity,membrane binding and uptake of the <Emphasis Type="Italic">Sclerotinia sclerotiorum</Emphasis> agglutinin (SSA) in different insect cell lines

The fungal lectin purified from Sclerotinia sclerotiorum, further referred to as Sclerotinia sclerotiorum agglutinin or SSA, possesses insecticidal activity against important pest insects such as pea aphids (Acyrthosiphon pisum). This paper aims at a better understanding of its activity at cellular level. Therefore, different insect cell lines were treated with SSA. These cell lines were derived from different tissues and represent the three major orders of insects important in agriculture: CF-203 (midgut Choristoneura fumiferana, Lepidoptera), GUTAW1 (midgut, Helicoverpa zea, Lepidoptera), High5 cells (ovary, Trichoplusia ni, Lepidoptera), Sf9 (ovary cells from Spodoptera frugiperda, Lepidoptera), S2 (hemocyte, Drosophila melanogaster, Diptera), and TcA (whole body, Tribolium castaneum, Coleoptera). Although the sensitivity to SSA differs between the cell lines, SSA clearly showed toxicity in all six cell lines with median effect concentrations (EC₅₀) ranging between 9 and 42 μg/ml. An in-depth analysis of the mechanism of uptake in the cells revealed superior amounts of FITC-SSA at the membrane of CF-203 cells compared to Sf9 cells, while a similar small amount of SSA was internalized in both cell lines. Pre-incubation with the clathrin-mediated endocytosis inhibitor phenylarsine oxide inhibited the internalization of SSA into the CF-203 and Sf9 cells with a respective reduction of 6- and 1.7-fold. The data are discussed in relation to the importance of cellular uptake mechanism for SSA binding and cytotoxicity.     

Developmental dynamics of myogenesis in the shipworm <Emphasis Type="Italic">Lyrodus pedicellatus</Emphasis> (Mollusca: Bivalvia)

Background

The shipworm Lyrodus pedicellatus is a wood-boring bivalve with an unusual vermiform body. Although its larvae are brooded, they retain the general appearance of a typical bivalve veliger-type larva. Here, we describe myogenesis of L. pedicellatus revealed by filamentous actin labelling and discuss the data in a comparative framework in order to test for homologous structures that might be part of the bivalve (larval) muscular ground pattern.

Results

Five major muscle systems were identified: a velum retractor, foot retractor, larval retractor, a distinct mantle musculature and an adductor system. For a short period of larval life, an additional ventral larval retractor is present. Early in development, a velum muscle ring and an oral velum musculature emerge. In late stages the lateral and dorsal mantle musculature, paired finger-shaped muscles, an accessory adductor and a pedal plexus are formed. Similar to other bivalve larvae, L. pedicellatus exhibits three velum retractor muscles, but in contrast to other species, one of them disappears in early stages of L. pedicellatus. The remaining two velum retractors are considerably remodelled during late larval development and are most likely incorporated into the elaborate mantle musculature of the adult.

Conclusions

To our knowledge, this is the first account of any larval retractor system that might contribute to the adult bodyplan of a (conchiferan) mollusk. A comparative analysis shows that a pedal plexus, adductors, a larval velum ring, velum retractors and a ventral larval retractor are commonly found among bivalve larvae, and thus most likely belong to the ground pattern of the bivalve larval musculature.

     

1alpha,25-Dihydroxyvitamin D3-induced down-regulation of the checkpoint proteins, Chk1 and Claspin, is mediated by the pocket proteins p107 and p130

A previous cDNA microarray analysis in murine MC3T3-E1 osteoblasts revealed a cluster of genes involved in cell cycle progression that was significantly down-regulated after a single treatment with 1alpha,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] [L. Verlinden, G. Eelen, I. Beullens, M. Van Camp, P. Van Hummelen, K. Engelen, R. Van Hellemont, K. Marchal, B. De Moor, F. Foijer, H. Te Riele, M. Beullens, M. Bollen, C. Mathieu, R. Bouillon, A. Verstuyf, Characterization of the condensin component Cnap1 and protein kinase Melk as novel E2F target genes down-regulated by 1,25-dihydroxyvitamin D3, J. Biol. Chem. 280 (45) (2005) 37319-37330]. Among those genes were the DNA replication and DNA damage checkpoint proteins, Chk1 and Claspin, of which the human homologues were recently shown to be E2F-responsive. Quantitative real-time PCR experiments in 1,25(OH)(2)D(3)-treated MC3T3-E1 cells confirmed the down-regulation observed in the microarray experiment. Moreover, Chk1 and Claspin promoter activities were also reduced after incubation with 1,25(OH)(2)D(3), and this reduction was mediated through the E2F recognition motifs within their promoters because mutation of these motifs almost completely abolished the repressive effect of 1,25(OH)(2)D(3). The antiproliferative effect of 1,25(OH)(2)D(3) as well as its potential to down-regulate the expression of Chk1 and Claspin depended on the pocket proteins p107 and p130 because 1,25(OH)(2)D(3) lost its antiproliferative action and failed to repress these E2F-target genes in p107(-/-);p130(-/-)-cells, but not in pRb(-/-)-cells.     

Atypical PKCzeta is involved in RhoA-dependent mitogenic signaling by the P2Y(12) receptor in C6 cells

When nucleotide hydrolysis is prevented, agonists of the P2Y(12) receptor enhance the proliferation of C6 glioma cells by RhoA-dependent, protein kinase C (PKC)-dependent activation of the extracellular signal-regulated kinase (ERK) pathway [Claes P, Grobben B, Van Kolen K, Roymans D & Slegers H (2001) Br J Pharmacol134, 402-408; Grobben B, Claes P, Van Kolen K, Roymans D, Fransen P, Sys SU & Slegers H (2001) J Neurochem78, 1325-1338]. In this study, we show that ERK1/2 phosphorylation was not affected by transfection of the cells with the Gbetagamma-subunit-scavenging adrenergic receptor kinase peptide [betaARK1-(495-689)] or with Rap1GAPII, indicating that P2Y(12) receptor stimulation enhances ERK1/2 phosphorylation by G(i)alpha subunit-mediated signaling independently of Rap1 activation. Inhibition of the RhoA downstream effector Rho-associated coiled-coil-containing kinase (ROCK) with Y-27632 did not affect the P2Y(12) receptor-induced increase in ERK1/2 phosphorylation but abrogated the mitogenic response. Involvement of growth factor receptor transactivation in the signaling towards ERK phosphorylation could be ruled out by the lack of an effect of PP2, AG1024, AG1296 or SU1498, inhibitors of Src, insulin-like growth factor receptor, platelet-derived growth factor receptor and vascular endothelial growth factor receptor kinase activity, respectively. Experiments with bisindolylmaleimide I and IX indicated the requirement of PKC activity. Classical and novel PKC isoforms could be excluded by treatment of the cells with G?6976 and calphostin C, whereas addition of a myristoylated PKCzeta pseudosubstrate inhibitor completely abolished P2Y(12) receptor-induced ERK1/2 activation. Moreover, coimmunoprecipitation experiments revealed PKCzeta/Raf1 and PKCzeta/ERK association, indicating the involvement of PKCzeta. From the data presented, we can conclude that the P2Y(12) receptor enhances cell proliferation by a G(i)alpha-dependent, RhoA-dependent PKCzeta/Raf1/MEK/ERK pathway that requires activation of ROCK, which is not involved in ERK1/2 signaling.     

Disproportionate Contribution of Riparian Inputs to Organic Carbon Pools in Freshwater Systems

A lack of appropriate proxies has traditionally hampered our ability to distinguish riverine organic carbon (OC) sources at the landscape scale. However, the dissection of C₄ grasslands by C₃-enriched riparian vegetation, and the distinct carbon stable isotope signature (δ¹³C) of these two photosynthetic pathways, provides a unique setting to assess the relative contribution of riparian and more distant sources to riverine C pools. Here, we compared δ¹³C signatures of bulk sub-basin vegetation (δ¹³C_VEG) with those of riverine OC pools for a wide range of sites within two contrasting river basins in Madagascar. Although C₃-derived carbon dominated in the eastern Rianala catchment, consistent with the dominant vegetation, we found that in the C₄-dominated Betsiboka basin, riverine OC is disproportionately sourced from the C₃-enriched riparian fringe, irrespective of climatic season, even though δ¹³C_VEG estimates suggest as much as 96% of vegetation cover in some Betsiboka sub-basins may be accounted for by C₄ biomass. For example, δ¹³C values for river bed OC were on average 6.9 ± 2.7‰ depleted in ¹³C compared to paired estimates of δ¹³C_VEG. The disconnection of the wider C₄-dominated basin is considered the primary driver of the under-representation of C₄-derived C within riverine OC pools in the Betsiboka basin, although combustion of grassland biomass by fire is likely a subsidiary constraint on the quantity of terrestrial organic matter available for export to these streams and rivers. Our findings carry implications for the use of sedimentary δ¹³C signatures as proxies for past forest-grassland distribution and climate, as the C₄ component may be considerably underestimated due to its disconnection from riverine OC pools.     

Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy

Asoprisnil is a novel selective steroid receptor modulator that shows unique pharmacodynamic effects in animal models and humans. Asoprisnil, its major metabolite J912, and structurally related compounds represent a new class of progesterone receptor (PR) ligands that exhibit partial agonist and antagonist activities in vivo. Asoprisnil demonstrates a high degree of receptor and tissue selectivity, with high-binding affinity for PR, moderate affinity for glucocorticoid receptor (GR), low affinity for androgen receptor (AR), and no binding affinity for estrogen or mineralocorticoid receptors. In the rabbit endometrium, both asoprisnil and J912 induce partial agonist and antagonist effects. Asoprisnil induces mucification of the guinea pig vagina and has pronounced anti-uterotrophic effects in normal and ovariectomized guinea pigs. Unlike antiprogestins, asoprisnil shows only marginal labor-inducing activity during mid-pregnancy and is completely ineffective in inducing preterm parturition in the guinea pig. Asoprisnil exhibits only marginal antiglucocorticoid activity in transactivation in vitro assays and animal models. In male rats, asoprisnil showed weak androgenic and anti-androgenic properties. In toxicological studies in female cynomolgus monkeys, asoprisnil treatment abolished menstrual cyclicity and endometrial atrophy. Early clinical studies of asoprisnil in normal volunteers demonstrated a dose-dependent suppression of menstruation irrespective of the effects on ovulation, with no change in basal estrogen concentrations and no antiglucocorticoid effects. Unlike progestins, asoprisnil does not induce breakthrough bleeding. With favorable safety and tolerability profiles thus far, asoprisnil appears promising as a novel treatment of gynecological disorders, such as uterine fibroids and endometriosis.